Molecular mechanisms of insulin resistance and associated diseases

被引:188
作者
Mlinar, Barbara
Marc, Janja
Janez, Andrej
Pfeifer, Marija
机构
[1] Univ Ljubljana, Dept Clin Biochem, Fac Pharm, SI-1000 Ljubljana, Slovenia
[2] Univ Ljubljana, Ctr Med, Dept Endocrinol & Metab Dis, Ljubljana, Slovenia
关键词
diabetes mellitus type 2; insulin resistance; lipodystrophy; metabolic syndrome; obesity; polycystic ovary syndrome;
D O I
10.1016/j.cca.2006.07.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
insulin resistance is a state in which higher than normal concentrations of insulin are required for normal response. The most common underlying cause is central obesity, although primary insulin resistance in normal-weight individuals is also possible. Excess abdominal adipose tissue has been shown to release increased amounts of free fatty acids which directly affect insulin signalling, diminish glucose uptake in muscle, drive exaggerated triglyceride synthesis and induce gluconeogenesis in the liver. Other factors presumed to play the role in insulin resistance are tumour necrosis factor alpha, adiponectin, leptin, IL-6 and some other adipokines. Hyperinsulinaemia which accompanies insulin resistance may be implicated in the development of many pathological states, such as hypertension and hyperandrogenaemia. Insulin resistance underlies metabolic syndrome and is farther associated with polycystic ovary syndrome and lipodystrophies. When IS-cells fail to secrete the excess insulin needed, diabetes mellitus type 2 emerges, which is, besides coronary heart disease, the main complication of insulin resistance and associated diseases. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:20 / 35
页数:16
相关论文
共 141 条
[81]  
NEEL JV, 1962, AM J HUM GENET, V14, P353
[82]   Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome [J].
Nelson-Degrave, VL ;
Wickenheisser, JK ;
Hendricks, KL ;
Asano, T ;
Fujishiro, M ;
Legro, RS ;
Kimball, SR ;
Strauss, JF ;
McAllister, JM .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (02) :379-390
[83]   Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system [J].
Nestler, JE ;
Jakubowicz, DJ ;
Falcon, A ;
Brik, VC ;
Quintero, N ;
Medina, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) :2001-2005
[84]   Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications [J].
Nestler, JE .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1997, 15 (02) :111-122
[85]   Biomedicine -: Separation of conjoined hormones yields appetite rivals [J].
Nogueiras, R ;
Tschöp, M .
SCIENCE, 2005, 310 (5750) :985-986
[86]   MJA practice essentials -: Endrocrinology -: 4:: Polycystic ovary syndrome [J].
Norman, RJ ;
Wu, RJ ;
Stankiewicz, MT .
MEDICAL JOURNAL OF AUSTRALIA, 2004, 180 (03) :132-137
[87]   Insights into obesity and insulin resistance from the study of extreme human phenotypes [J].
O'Rahilly, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (04) :435-441
[88]   THE REGULATION OF LIPOPROTEIN-LIPASE GENE-EXPRESSION BY DEXAMETHASONE IN ISOLATED RAT ADIPOCYTES [J].
ONG, JM ;
SIMSOLO, RB ;
SAFFARI, B ;
KERN, PA .
ENDOCRINOLOGY, 1992, 130 (04) :2310-2316
[89]   EFFECT OF FATTY-ACIDS ON INSULIN RELEASE - ROLE OF CHAIN-LENGTH AND DEGREE OF UNSATURATION [J].
OPARA, EC ;
GARFINKEL, M ;
HUBBARD, VS ;
BURCH, WM ;
AKWARI, OE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :E635-E639
[90]   Leptin-replacement therapy for lipodystrophy [J].
Oral, EA ;
Simha, V ;
Ruiz, E ;
Andewelt, A ;
Premkumar, A ;
Snell, P ;
Wagner, AJ ;
DePaoli, AM ;
Reitman, ML ;
Taylor, SI ;
Gorden, P ;
Garg, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) :570-578